Christine Peoples

Christine Peoples practices at UPMC Cole in Coudersport, Pennsylvania, part of University of Pittsburgh Medical Center.

Christine Peoples' NPI, 1003063348, was assigned on August 19, 2008. Christine Peoples holds Pennsylvania license MD447573.

Christine Peoples' primary practice is UPMC Cole, at 1001 East Second Street, Coudersport, PA 16915 in Potter County. The practice phone is (814) 274-9301.

Christine Peoples' primary practice is UPMC Cole in Coudersport, Pennsylvania, part of University of Pittsburgh Medical Center. Christine Peoples is also affiliated with UPMC Northwest. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Christine Peoples to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christine Peoples practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Christine Peoples' primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Christine Peoples is board certified in rheumatology by the American Board of Internal Medicine. Christine Peoples is licensed in Pennsylvania.

CMS data shows 63 Medicare services from Christine Peoples across 2 procedure codes in 2024, all of them office visits, for 57 Medicare patients. Medicare paid $5,173 for them. Every service was in an office.

CMS counts 57 Medicare patients who saw Christine Peoples in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have arthritis, and 74% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Christine Peoples' median patient age at 68, with 79% women.

In 2024, Christine Peoples wrote 1,025 Medicare Part D claims for 112 patients. 71% of them were for generic drugs. CMS names the drug for 873 of them, across 17 drugs with 11 or more claims each, at $1,192,492 in total drug cost. In 2023, CMS named 788 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Christine Peoples for performance year 2024, reported as part of a group. Christine Peoples accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Christine Peoples as offering telehealth.

Dmand AI links 7 papers to Christine Peoples, published from 2010 to 2024. The most frequent topics are Arthritis, Rheumatoid and Estradiol. Christine Peoples has published most often in Arthritis Res Ther. Christine Peoples' most frequent co-authors are Daniel A. Albert, MD, Deanna Andrea Baker Frost, MD, PhD and Marcy B. Bolster, MD.

Dmand AI links Christine Peoples to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 4 general payments to Christine Peoples from 2 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 65% of the total. Pfizer Inc. paid the most, $10,600.